Pathological features of triple‐negative breast cancers that showed progressive disease during neoadjuvant chemotherapy

Clinical progressive disease (cPD) occurs during neoadjuvant chemotherapy (NAC) in 3%–5% of triple‐negative breast cancer (TNBC) patients. We aimed to identify the histopathological and immunohistochemical parameters that are correlated with the TNBC that showed cPD. We identified 22 TNBCs that show...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanabe, Yuko, Tsuda, Hitoshi, Yoshida, Masayuki, Yunokawa, Mayu, Yonemori, Kan, Shimizu, Chikako, Yamamoto, Seiichiro, Kinoshita, Takayuki, Fujiwara, Yasuhiro, Tamura, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497804/
https://www.ncbi.nlm.nih.gov/pubmed/28474753
http://dx.doi.org/10.1111/cas.13274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497804/
https://www.ncbi.nlm.nih.gov/pubmed/28474753
http://dx.doi.org/10.1111/cas.13274

Ejemplares similares